Operating Company Healthcare

TRC Healthcare

Denver, Colorado, United States

Empowering healthcare professionals to reduce medication errors and improve patient care through trusted, evidence-based recommendations and continuing education on drug therapy and medication management.

Focus Areas
Medication safety, Drug therapy recommendations, Clinical education/CE

Tracked deals

5

5 tracked deals across 2020-2022.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout · 2 addon

TRC Healthcare Acquisition Volume by Year

Last 3 years

Acquisition volume by year Annual acquisition counts for the last 3 years for TRC Healthcare. 2 2020 2 2021 1 2022

Supporting Data

Recent Transactions

  • Buyer
    TRC Healthcare
    Target
    QURE Healthcare
    Type
    Buyout

    TRC Healthcare, a Denver-based provider of continuing education for healthcare professionals, has acquired QURE Healthcare to scale QURE's Clinical Performance and Value (CPV) patient simulation software and strengthen TRC's evidence-based education offerings. QURE founder Dr. John Peabody will continue as QURE's president and will also serve as Chief Medical Officer at TRC, as the acquisition aims to reduce unwarranted variation in care and improve patient outcomes.

  • Buyer
    TRC Healthcare
    Target
    Bula Intelligence
    Type
    Buyout

    TRC Healthcare has acquired Bula Intelligence, a subscription-based provider of regulatory and legislative tracking for U.S. pharmacies. The acquisition expands TRC's compliance and regulatory coverage for pharmacies and complements its existing continuing-education and advisory offerings.

  • Buyer
    Therapeutic Research Center, LLC (TRC), Levine Leichtman Capital Partners (LLCP)
    Target
    CE Resources, Inc. (d/b/a NetCE)
    Type
    Addon

    Therapeutic Research Center (TRC), a portfolio company of Levine Leichtman Capital Partners (LLCP), has acquired CE Resources, Inc., d/b/a NetCE, a Roseville, California–based continuing education platform for healthcare professionals. The acquisition expands TRC's clinician education platform and content library to reach a broader set of nurses, physicians and mental health professionals.

  • Buyer
    Therapeutic Research Center, LLC (TRC), Levine Leichtman Capital Partners
    Target
    CriticalPoint, LLC, Clinical IQ, LLC
    Location
    United States
    Type
    Addon

    Therapeutic Research Center (TRC), a portfolio company of Levine Leichtman Capital Partners, has acquired CriticalPoint, LLC and Clinical IQ, LLC to expand its sterile compounding training, consulting and compliance capabilities. The deal augments TRC's education platform and strengthens its domain expertise in compounding, aseptic processing and USP compliance.

  • Buyer
    TRC Healthcare (Therapeutic Research Center)
    Target
    CriticalPoint, LLC, Kastango Consulting Group (formerly Clinical IQ, LLC)
    Type
    Buyout

    TRC Healthcare (Therapeutic Research Center) acquired CriticalPoint, LLC and Kastango Consulting Group (formerly Clinical IQ, LLC) to expand its sterile and non-sterile compounding training, eLearning, and consulting offerings. The deal brings CriticalPoint's eLearning, live training, SOPs and peer networks together with Kastango's customized consulting services to strengthen TRC's medication safety and clinical education portfolio.

Related Acquisition Pages

Selling a company? Get in front of buyers like TRC Healthcare

Turn tracked acquisition activity into an outreach-ready buyer list.